Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 1 ~ 20 of 1696, Page 1 of 86
1. CDC and FDA Investigate Lung Illnesses Linked to Vaping
Federal experts are investigating reports of severe lung illnesses in people who used e-cigarettes (also known as vaping).
09/03/2019 American Cancer Society
2. New Study Finds Abbott''s Blood Test Technology Could Help Detect Brain Injury Quickly, Even if CT Scan is Normal
The TRACK-TBI study found that 64% of people with the highest levels of a protein in the blood were confirmed to have brain injury through an MRI scan, even when a CT scan did not detect it / Abbott's diagnostic test, currently in development, is poised to be the first point-of-care blood test for assessing concussions on its next generation i-STAT™ device, providing doctors results in 15 minutes
08/26/2019 Abbott
3. Abbott and Intoximeters Partner to Keep Roads Safer by Bringing Together Industry-leading Technology for Drug and Alcohol Testing
Agreement gives law enforcement access to the most advanced handheld tools to help detect drug and alcohol-impaired drivers / Collaboration is a major step in keeping roads safer as recreational marijuana legalization accelerates[1]
08/14/2019 Abbott
4. Medtronic Requests Approval of Non-Adjunctive Labeling from FDA
DUBLIN, July 23, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT),?the global leader in medical technology, services and solutions, today announced its Premarket Approval (PMA) submission to the U.S. Food and Drug Administration (FDA) requesting approval for non-adjunctive labeling for its Guardian™ Sensor 3, as part of the MiniMed™ 670G system. If the FDA approves a sensor with non-adjunctive labeling, it means that a sensor is accurate enough to be used to calculate an insulin dose for meals and to correct high glucose levels. Since Medicare requires a non-adjunctive label for sensor reimbursement, if approved, this labeling could broaden patient access by allowing for Medicare coverage of the world’s first and still the only commercially available hybrid closed loop system.
07/23/2019 Medtronic
5. WHO recommends dolutegravir as preferred HIV treatment option in all populations
07/22/2019 WHO
6. FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available
07/17/2019 MERCK
7. Abbott Announces FDA Approval of the Alinity™ s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply
Alinity™ s System will screen the U.S. blood and plasma supply faster and more efficiently while maintaining highest levels of accuracy
07/11/2019 Abbott
8. WHO updates global guidance on medicines and diagnostic tests to address health challenges, prioritize highly effective therapeutics, and improve affordable access
New essential medicines and diagnostics lists published today
07/09/2019 WHO
9. In the face of slow progress, WHO offers a new tool and sets a target to accelerate action against antimicrobial resistance
06/18/2019 WHO
10. Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes
Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation / Assay is the first and only rapid point-of-care test cleared by the U.S. Food and Drug Administration (FDA) to aid healthcare professionals in the diagnosis of diabetes
06/17/2019 Abbott
11. New Survey Shows Millennials Can Help Avoid Blood Shortages
45% of blood donations have historically come from people over 50 years old, but that number is declining / As more millennials bring their passion to blood donation, they can fill the gap left by aging baby boomers
06/13/2019 Abbott
12. Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes
ugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance
06/10/2019 Medtronic
13. Current Legal Cannabis Driving Limits in U.S., Europe Are Ineffective According to Breaking Research in AACC뭩 Clinical Chemistry Journal
New findings, published today in AACC뭩 Clinical Chemistry journal, add to a growing body of evidence suggesting that no legal driving limit for cannabis can catch impaired recreational users without unfairly penalizing unimpaired regular or medicinal users.
05/14/2019 AACC
14. Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., on efforts to promote and foster blood pathogen reduction technologies
03/26/2019 U.S. FOOD & DRUG ADMINISTRATION
15. Abbott''s Latest Diagnostics Technology, Alinity, Selected by Regional Medical Laboratory, Inc. to Deliver Benefits to Hospitals and Patients
Regional Medical Laboratory, Inc., which is part of the Ascension network, partners with Abbott, the global health leader, to advance lab capabilities and help improve health outcomes
03/05/2019 Abbott
16. FDA warns patients and doctors about recall of home-use test strips used with device to monitor blood thinner warfarin, not authorized for sale in U.S.
02/01/2019 U.S. FOOD & DRUG ADMINISTRATION
17. FDA statement from Commissioner announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications
Risk Evaluation and Mitigation Strategy (REMS)
01/24/2019 U.S. FOOD & DRUG ADMINISTRATION
18. Japanese Red Cross Society Selects Abbott Technology to Screen Country''s Blood and Plasma Supply
LONG-TERM AGREEMENT BETWEEN JAPANESE RED CROSS SOCIETY AND ABBOTT BRINGS TOGETHER TWO GLOBAL LEADERS IN BLOOD AND PLASMA SCREENING, HELPING ENSURE A SAFE AND EFFICIENT BLOOD SUPPLY ACROSS JAPAN
01/17/2019 Abbott
19. FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk
Miris Human Milk Analyzer, a new diagnostic test to aid healthcare professionals in measuring nutrients in breast milk, including the concentration of fat, carbohydrate, protein, total solids and energy
12/21/2018 U.S. FOOD & DRUG ADMINISTRATION
20. Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products
One challenge we face right now, when it comes to developing diagnostics that can help target the delivery of cancer drugs, is the way these diagnostics are sometimes labeled.
12/06/2018 U.S. FOOD & DRUG ADMINISTRATION
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱